Clinical Study

Pulmonary Hypertension in Dialysis Patients: A Cross-Sectional Italian Study

Table 2

Clinical and laboratory data of patients with and without pulmonary hypertension.

PAP 35PAP 35

Age (year)59 ± 1461 ± 12ns
Male/Female ( (%))22/1215/7ns
Diabetes ( (%))1 (3%)4 (18%)0.05
Smoking history ( (%))19 (56%)17 (77%)ns
Dialysis vintage (months)27 ± 3263 ± 600.0105
Dry weight (kg)70 ± 1665 ± 13ns
Interdialytic weight gain (kg)1,3 ± 0,92,0 ± 1.00.0168
Systolic blood pressure (mmHg)132 ± 15132 ± 27ns
Diastolic blood pressure (mmHg)80 ± 873 ± 120.0102
Calcium (mg/dl)8,9 ± 19 ± 1ns
Phosphate (mg/dl)5,2 ± 1,75,2 ± 0,9ns
Calcium-phosphate product (mg2/dl2)48 ± 1848 ± 10ns
PTH (pg/ml)316 ± 313388 ± 381ns
Haemoglobin (gr/dl)11,4 ± 1,511 ± 1,4ns
Haematocrit (%)36 ± 534 ± 5ns
Erythropoietin (IU/week)5980 ± 76649272 ± 10015ns